Adugnaw Atnafu Atalay1, Reta Kassa Abebe2, Aberash Eifa Dadhi3, Worku Ketema Bededa4. 1. Department of Internal Medicine, College of Health Sciences, St Paul Millennium College, Addis Ababa, Ethiopia. 2. School of Public Health, College of Health Sciences, Dilla University, Dilla, Ethiopia. 3. Department of Midwifery, College of Health Sciences, Hawassa University, Hawassa, Ethiopia. 4. Department of Pediatrics and Child Health, College of Health Sciences, Hawassa University, Hawassa, Ethiopia.
Abstract
INTRODUCTION: A pregnancy that has been complicated with Hepatitis B virus (HBV) infection results in typical management problems for both the mother and the newborn. One of the universal efforts in tackling the impact of chronic HBV is the prevention of mother-to-child transmission during Antenatal care via prompt screening as the majority of chronic infections globally harbored during this period. Rewarding result have been achieved in reducing this problem at this period of life through maternal screening programs and universal vaccination of infants. This study was aimed at assessing the seroprevalence and associated risk factor of HBV among pregnant women attending Antenatal Care (ANC) in Dilla University Referral Hospital (DURH), Southern Ethiopia. METHOD: A facility- based cross- sectional study was conducted from December 01 to May 30, 2017 among pregnant women attending ANC. A total of 236 pregnant women were included in this study. All Pregnant women who were attending antenatal clinic and were volunteer during the study period were included, whereas those women who were unable to communicate due to any problem, and not volunteer to give informed consent were excluded. Volunteer participants were asked to complete a questionnaire and had offered to test for HBsAg infection. The data was analyzed using SPSS version 20 software. Logistic regression was used to determine the association between dependent and independent variables. RESULTS: From 215 pregnant women attending ANC, the prevalence of HBsAg by the rapid test was found to be 11 (5.1%). Among the study participants, 91.1% (215) were tested for HIV antibody during the ANC visit, with the positivity rate of 4.5%. The result showed 1.86% of the study participants who were tested for HIV were also positive for HBsAg. Among those factors affecting the transmission of HBV infection, multiple partners and HIV confection have significant association at P-value less than 0.05. CONCLUSION: The Seropositivity of Hepatitis B Virus among Pregnant Women was found to be significant and hence, routine screening of pregnant mother at Antenatal care for this virus, and subsequent management according to the guideline for both the mother and child is recommended.
INTRODUCTION: A pregnancy that has been complicated with Hepatitis B virus (HBV) infection results in typical management problems for both the mother and the newborn. One of the universal efforts in tackling the impact of chronic HBV is the prevention of mother-to-child transmission during Antenatal care via prompt screening as the majority of chronic infections globally harbored during this period. Rewarding result have been achieved in reducing this problem at this period of life through maternal screening programs and universal vaccination of infants. This study was aimed at assessing the seroprevalence and associated risk factor of HBV among pregnant women attending Antenatal Care (ANC) in Dilla University Referral Hospital (DURH), Southern Ethiopia. METHOD: A facility- based cross- sectional study was conducted from December 01 to May 30, 2017 among pregnant women attending ANC. A total of 236 pregnant women were included in this study. All Pregnant women who were attending antenatal clinic and were volunteer during the study period were included, whereas those women who were unable to communicate due to any problem, and not volunteer to give informed consent were excluded. Volunteer participants were asked to complete a questionnaire and had offered to test for HBsAg infection. The data was analyzed using SPSS version 20 software. Logistic regression was used to determine the association between dependent and independent variables. RESULTS: From 215 pregnant women attending ANC, the prevalence of HBsAg by the rapid test was found to be 11 (5.1%). Among the study participants, 91.1% (215) were tested for HIV antibody during the ANC visit, with the positivity rate of 4.5%. The result showed 1.86% of the study participants who were tested for HIV were also positive for HBsAg. Among those factors affecting the transmission of HBV infection, multiple partners and HIV confection have significant association at P-value less than 0.05. CONCLUSION: The Seropositivity of Hepatitis B Virus among Pregnant Women was found to be significant and hence, routine screening of pregnant mother at Antenatal care for this virus, and subsequent management according to the guideline for both the mother and child is recommended.
Authors: A B Olokoba; F K Salawu; A Danburam; L B Olokoba; J K Midala; L H Badung; Awo Olatinwo Journal: Niger J Clin Pract Date: 2011 Jan-Mar Impact factor: 0.968
Authors: Rainer Weber; Caroline A Sabin; Nina Friis-Møller; Peter Reiss; Wafaa M El-Sadr; Ole Kirk; Francois Dabis; Matthew G Law; Christian Pradier; Stephane De Wit; Börje Akerlund; Gonzalo Calvo; Antonella d'Arminio Monforte; Martin Rickenbach; Bruno Ledergerber; Andrew N Phillips; Jens D Lundgren Journal: Arch Intern Med Date: 2006 Aug 14-28
Authors: Douglas K Owens; Karina W Davidson; Alex H Krist; Michael J Barry; Michael Cabana; Aaron B Caughey; Chyke A Doubeni; John W Epling; Alex R Kemper; Martha Kubik; C Seth Landefeld; Carol M Mangione; Lori Pbert; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong Journal: JAMA Date: 2019-07-23 Impact factor: 56.272
Authors: Ahizechukwu C Eke; Uzoamaka A Eke; Charles I Okafor; Ifeanyichukwu U Ezebialu; Chukwuanugo Ogbuagu Journal: Virol J Date: 2011-01-12 Impact factor: 4.099
Authors: Benjamin Ansah Dortey; Emmanuel Anongeba Anaba; A T Lassey; N K R Damale; Ernest T Maya Journal: PLoS One Date: 2020-04-22 Impact factor: 3.240
Authors: Olatunji M Kolawole; Abideen A Wahab; Daniel A Adekanle; Timothy Sibanda; Anthony I Okoh Journal: Virol J Date: 2012-12-27 Impact factor: 4.099
Authors: Daniel Gebretsadik; Minilik Assefa; Genet Molla Fenta; Chala Daba; Abdurrahman Ali; Saba Gebremichael Tekele Journal: Biomed Res Int Date: 2022-08-28 Impact factor: 3.246